BIMATOPROST SANDOZ 0.1 mg/ml, eye drop solution bottle, 3 ml
Active ingredients: Bimatoprost
Commercialized according to BDPMDispensing in France: Prescription only
Eye drop solutionbottle, 3 mlophtalmique
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BIMATOPROST SANDOZ 0,1 mg/mL, collyre en solution
- Pharmaceutical form
- collyre en solution
- Route of administration
- ophtalmique
- Presentation description
- 1 flacon(s) compte-gouttes polyéthylène basse densité (PEBD) de 3 ml
- Marketing authorisation holder
- SANDOZ
- Reimbursement according to BDPM
- 65 %
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 20 May 2022
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69276143CIP73010084CIP133400930100844Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| BIMATOPROSTcollyre | 0,1 mg · 1 mL de solution | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.